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Abstract Gelsolin is a widely distributed Ca -dependent 
regulator of the cortical actin network. We demonstrate that 
gelsolin is phosphorylated by pp60c~src and that this phospho-
rylation is dramatically enhanced by phosphatidylinositol 4,5-
bisphosphate (PIP2), known to specifically interact with gelsolin. 
Other phospholipids display only a marginal effect. pp56lck, a 
tyrosine kinase of the same family, does not phosphorylate 
gelsolin. Other mammalian actin-binding proteins such as 
profilin and CapG but also fragmin from Physamm polycepha-
lum are similar targets for PIP2-stimulated pp60
c"src phospho-
rylation. 
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1. Introduction 
pp60c-src is the normal cellular counterpart of the trans-
forming protein of Rous sarcoma virus (RSV) pp60v_src and 
is a membrane-associated non-receptor tyrosine kinase (for 
reviews see [1,2]). This kinase plays an important role in the 
control of cell division [3], cell growth and differentiation [4] 
and has a distinctive function in bone formation [5]. Signifi-
cant amounts of pp60c_src are present in blood platelets [6] 
and neurons [7] suggesting that the role of pp60c-src is not 
only restricted to growth and differentiation of proliferating 
cells but may display other functions. 
Next to autophosphorylation [8] resulting in its activation, 
pp60c-src is known to phosphorylate a number of other target 
proteins including ppl25 focal adhesion kinase [9], p80/85 
cortactin [10,11], an actin filament-binding protein [12], the 
ras GTPase activating protein [13] and possibly also the p85 
regulatory subunit of phosphatidylinositol-3 kinase (PI-3 ki-
nase) [14]. 
Gelsolin is a actin-binding protein (82 kDa) present in the 
cytoplasm of vertebrate cells and blood plasma [15,16]. The 
secreted form is structurally similar to the cytoplasmic iso-
form but has an additional leader sequence of 25 amino acids. 
Both proteins are encoded by a single gene and the isoforms 
have the same functional properties. In vitro, gelsolin severs 
actin filaments, caps the fast-growing end and promotes 
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growth of actin filaments by creating nucleation sites 
[15,17,18]. These activities are enhanced by Ca2+ whereas 
polyphosphoinositides such as PIP2 and PIP are known to 
act as inhibitors, in particular of the severing activity (re-
viewed in [19]). Polyphosphoinositides can also uncap gelsolin 
from the fast-growing end of actin filaments in vivo, and thus 
indirectly promote actin filament growth [20]. 
Several members of the gelsolin family are phosphorylated 
in vitro and/or in vivo by different protein kinases. For in-
stance, CapG, a strictly actin-capping protein, is phosphoryl-
ated in macrophages on serine and threonine residues but 
neither the corresponding kinase nor the sites have yet been 
identified [21]. Also profilin, a ubiquitously expressed small 
actin monomer binding protein was reported to be phos-
phorylated in vitro by protein kinase C (PKC). Interestingly, 
PIP2 stimulated this activity by modifying the nature of the 
profilin-PKC interaction [22]. Fragmin, a Ca2+-dependent ac-
tin-binding protein from Physarum polycephalum displaying 
properties similar to gelsolm, is phosphorylated by two var-
iants of an endogenous casein kinase II [23]. 
It has been stated previously that gelsolin is neither phos-
phorylated in macrophages [21] nor in Rous sarcoma virus-
transformed rat cells [24], although indirect evidence supports 
the opposite since recently Chellaiah and Hruska [25] sug-
gested that in osteoclasts pp60c_src and gelsolin could interact 
transiently with each other. Osteopontin was found to stimu-
late the association of phosphoinositides with gelsolin through 
stimulation of the PI-3 kinase. It was therefore postulated that 
pp60c~src could be the linker molecule between gelsolin and 
PI-3 kinase [25]. 
In the present study we have investigated phoshorylation of 
gelsolin by pp60c_src. We show that phospholipids, in partic-
ular PIP2 and PIP, dramatically enhance the tyrosine-specific 
phosphorylation of gelsolin. This finding suggests a new reg-
ulatory role for PIP2. pp56lck, another member of the src-
kinase family, did not phosphorylate gelsolin, illustrating the 
specificity of pp60c_src for gelsolin. We further show that the 
effect of PIP2 is not restricted to gelsolin alone but also ap-
plies to other actin-binding proteins such as profilin, fragmin 
and CapG. The results are discussed in terms of a possible 
direct role of pp60c~src in the organization of the actin mesh-
work associated with the plasma membrane of eukaryotic 
cells. 
2. Materials and methods 
2.1. Materials 
Nitrocellulose was obtained from Amersham (Buckinghamshire, 
UK). Whatman 3MM paper was from Whatman (Maidstone, UK). 
Cyanogen bromide activated Sepharose beads were purchased from 
Pharmacia/LKB (Uppsala, Sweden). DNase I was from Worthington 
biochemical corporation (New Jersey, USA). [γ-32Ρ]ΑΤΡ (4500 Ci/ 
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mmol) was from ICN Biochemicals (Costa Mesa, USA). Poly(L-pro-
line) (average Mr 10000-30000 Da) was from Sigma (St. Louis, MO). 
Cellulose thin-layer plates were obtained from Merck (Darmstadt, 
Germany). 
2.2. Proteins 
Gelsolin and CapG were purified from human plasma according to 
Cooper et al. [26] and Johnston et al. [27], respectively. The experi-
ments were performed with plasma gelsolin; some experiments (indi-
cated in the text) were repeated with cytoplasmic gelsolin that was 
purified as described by Bryan [28]. Recombinant fragmin and platelet 
profilin were purified as described by T'Jampens et al. (unpublished 
results) and by Lind et al. [29], respectively. Monoclonal anti-gelsolin 
antibodies were obtained from Sigma (St. Louis, MO). Biotin-conju-
gated 4G10 anti-phosphotyrosine antibody was obtained from Up-
state Biotechnology Incorporated (UBI, New York, NY). pp60c-src 
(recombinant human src kinase) with a specific activity of 900 000 VI 
mg kinase transferred 2 pmol/min per unit to the src kinase substrate 
peptide. pp56lck (partially purified from membrane fractions of bovine 
thymus) with a specific activity of 6406 U/mg transferred more than 
1 pmol phosphate/min per mg kinase to src kinase substrate peptide. 
PKC (a mixture of α-, β- and γ-isoforms) was isolated from rat brain 
and transferred 22.86 μιηοΐ 32P/min per mg enzyme to the PKC sub-
strate peptide. The three kinases were all obtained from UBI. 
2.3. Preparation of lipids 
Phospholipids that were obtained as a lyophilized salt were dis-
solved in water at the indicated concentrations (PIP2, 5 mM; PIP, 
1 mM; PI, 1 mM; PA, 5 mM and PS, 1 mM). Other phospholipids 
obtained as chloroform solutions (PC, PE) were dried in a stream of 
nitrogen and dissolved in 10 mM Tris-HCl, pH 8.0, at a concentration 
of 5 mM. Ceramide was dissolved in ethanol at 10 mM. All the lipids 
were sonicated for 30 min in a Branson S75 sonicator (Branson Sonic 
Power Co., Danbury, CT) and stored in aliquots at -80°C. PC, PE 
and to a lesser extent PS remained turbid after sonication. Before use 
the lipids were sonicated for an additional 5 min. 
2.4. Phosphorylation assays 
Phosphorylation of gelsolin was carried out at 30°C for the indi-
cated periods of time with or without PIP2 in a total volume of 12.5 μΐ 
containing 2.5 μΜ gelsolin, 10 mM MgCl2, 100 μΜ [γ-
32Ρ]ΑΤΡ (spe-
cific radioactivity 1000-1500 cpm/pmol) and 2.5 U pp60c-src or 2.5 U 
pp56lck in 10 mM Tris-HCl, pH 7.5, and 1 mM DTT. Gelsolin was 
preincubated with PIP2 for 30 min at RT with 30-, 60- or 90-fold 
molar excess over gelsolin, corresponding with 75 μΜ, 150 μΜ and 
225 μΜ, respectively. Phosphorylation of gelsolin (2.5 μΜ) with PKC 
(15 ng) was performed in the presence of 80 μg/ml phosphatidylserine 
and 0.4 mM Ca2+. Reactions were terminated by the addition of 5X 
concentrated Laemmli sample buffer [30] and analyzed by ID SDS-
polyacrylamide mini-slab gel electrophoresis [31]. The radioactivity 
incorporated into gelsolin was detected by autoradiography and quan-
tified by scanning the aiitoradiograms with a 2202 Ultroscanner 
(Pharmacia/LKB) or by Cerenkov counting of the exised gel bands 
using a Wallac 1409 scintillation counter (Pharmacia/LKB). 
Phosphorylation of fragmin (2.5 μΜ), CapG (2.5 μΜ) and profilin 
(7 μΜ) with pp60c~src (2.5 U) was carried out as described for gelso-
lin. 
2.5. Phospho-amino acid analysis 
Gelsolin (2 μΜ), preincubated with PIP2 (30-fold molar excess rel-
ative to gelsolin) was phosphorylated for 1 h with PKC (150 ng) or 
pp60c-src (30 U) in a total volume of 60 μΐ. Phosphogelsolin was 
purified by reversed-phase high performance liquid chromatography 
through a Cig column (4.6X250 mm, 5 mM particle size, 300 A pore 
size, Vydac, Separations Group, Hesperia, CA) equilibrated in 0.1% 
trifluoroacetic acid (TFA) and proteins were eluted with a linear gra-
dient of 0-90% acetonitrile in 0.1% TFA at a flow rate of 1 ml/min. 
The gradient was started 5 min after sample loading and terminated 
after 70 min. Phosphorylated gelsolin eluted after 45 min and was 
dried in a Speed-Vac (Savant Instruments, Farmingdale, NY) and 
hydrolyzed with 6 N HC1 for 2 h at 110°C. One-dimensional cellulose 
thin-layer chromatography was performed as described by Ejiri [32]. 
Radioactive amino acids were detected by autoradiography and the 
unlabeled standards were stained with ninhydrin. 
2.6. Miscellaneous 
Protein concentrations were determined by the method of Bradford 
[33] using bovine serum albumin as standard. 
The gelsolin peptide 160-QRLFQVKGRR-169 was synthesized 
with a 431A peptide synthesizer (Applied Biosystems). 
Western blot analysis was performed as described by Towbin et al. 
[34]. The biotin-conjugated anti-phosphotyrosine monoclonal anti-
body was used at a concentration of 1 μg/ml and incubated with 
gelsolin overnight at 4°C. The secondary streptavidin-conjugated al-
kaline phosphatase (Sigma) was diluted 1:2000 and incubated with the 
primary immunecomplex for 2 h at room temperature. 
3. Results 
3.1. Phosphorylation of gelsolin by pp60c~STC is stimulated by 
PIP2 
In an earlier report it was mentioned that fragmin, an actin-
binding protein of the gelsolin family and isolated from P. 
polycephalum, was phosphorylated by pp60 c _ s r c [35]. The tyr-
osine residue in the 114-LDDYL-118 motif was postulated as 
a candidate target [36] in view of its conformity with pp60 s r c 
consensus phosphorylation sites [37] and because this con-
served region was predicted to be an actin-binding site [38]. 
Based on more recent X-ray crystallographic data from the 
Si-gelsolin-actin complex [39], the importance in actin binding 
of this motif was confirmed. This raised the attractive hypoth-
esis of regulation of actin binding through pp60 c _ s r c phos-
phorylation. These observations and a more recent report 
alluding to an association between gelsolin and pp60c~ s r c 
[25], prompted us to investigate in more detail the possible 
phosphorylation of gelsolin by pp60 c _ s r c . 
When gelsolin was incubated with recombinant pp60 c _ s r c 
and Mg2 + /[y-3 2P]ATP we noticed a time dependent phospho-
Fig. 1. Phosphorylation of gelsolin by pp60c~src and stimulation by 
PIP2. A: Western blot analysis of gelsolin phosphorylation by 
pp60c~src in the absence of PIP2. Gelsolin (2.5 μΜ) was phosphoryl-
ated for the indicated time intervals with 2.5 U recombinant 
pp60c~src and Western blotted with anti-phosphotyrosine antibodies. 
pp60c_src is visible as an autophosphorylated band of 60 kDa. B: 
Stimulation of gelsolin phosphorylation by PIP2. Gelsolin (2.5 μΜ) 
was preincubated with the indicated concentrations of PIP2 for 30 
min at room temperature and then phosphorylated with 2.5 U of 
pp60c_src for 10 min. The phosphorylation mixture was analyzed by 
SDS-PAGE and autoradiography (overnight exposure at —80°C). c: 
control, gelsolin phosphorylation in the same conditions as above 
but in the absence of PIP2 (left panel). Anti-phosphotyrosine Wes-
tern blot of gelsolin phosphorylated by pp60c_src in the absence and 
presence of 75 μΜ PIP2 (right panel). C. pp56
lck does not phos-
phorylate gelsolin. Experimental conditions were the same as in A. 
Note the autophosphorylation of pp56lck as well as two other tyro-
sine phosphorylated proteins present in the partially purified pp56lck 
preparation. 
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rylation of gelsolin (Fig. 1A). A slower rate of phosphoryla-
tion was observed when Mn2+ was substituted for Mg2+ (data 
not shown). Western blot analyses with monoclonal anti-
phosphotyrosine antibodies confirmed that gelsolin was phos-
phorylated on tyrosine residue(s) (Fig. 1A). 
PIP2 is known to associate tightly with gelsolin in vitro and 
in vivo [40,20], inhibiting gelsolin's F-actin-severing activity 
[41]. Interestingly, Hansson et al. [22] demonstrated that 
PIP2 stimulates profilin phosphorylation by PKC. We there-
fore analyzed the effect of this phospholipid on pp60c~src-
mediated phosphorylation of plasma gelsolin or cytoplasmic 
gelsolin after preincubation with various concentrations of 
PIP2. A very strong stimulation of gelsolin phosphorylation 
was noticed (Fig. IB). A 30-fold molar excess of PIP2 (75 μΜ) 
relative to gelsolin resulted in a 25-fold increase of gelsolin 
phosphorylation by pp60c~src. This was measured after 10 min 
phosphorylation by densitometric scanning of the correspond-
ing autoradiogram or by counting the radiolabel. The corre-
sponding phospho-amino acid analysis is shown in Fig. 5B. 
The degree of phosphorylation further increased by 40% when 
the reaction was allowed to proceed for 90 min. Higher con-
centrations of PIP2 (225 μΜ; a 90-fold molar excess) pro-
duced an additional increase of 32P-incorporation, resulting 
in up to 30-fold increase of gelsolin phosphorylation by 
pp60c_src measured after 10 min (Fig. IB). 
In the absence of PIP2 we measured an incorporation of 
0.007 mol phosphate/mol of gelsolin. However, in the pre-
sence of a 30-fold or 90-fold molar excess of PIP2, stoichi-
ometries of 0.12 mol phosphate/mol of gelsolin and 0.18 mol 
phosphate/mol of gelsolin were observed, respectively. Using a 
reciprocal Michaelis-Menten plot, we derived a Km value of 
~ 6 μΜ. 
3.2. pp56l& does not phosphorylate gelsolin 
The 56 kDa T lymphocyte-specific tyrosine kinase pp56lck is 
a member of the src family and has been implicated in T-cell 
maturation and activation [42,43]. To determine the specificity 
of tyrosine kinases able to phosphorylate gelsolin, we studied 
the phosphorylation of gelsolin by pp56lck. pp56lck, obtained 
as a partially purified preparation from membranes of bovine 
thymus, was not able to phosphorylate gelsolin on tyrosine as 
demonstrated by Western blot analysis (see Fig. 1C). Even in 
the presence of PIP2 no phosphorylation was observed. Tyr-
osine phosphorylation activity by pp56lck was evidenced by 
Fig. 2. PIP2 enhances phosphorylation through association with gel-
solin. PIP2 (75 μΜ) was preincubated with various concentrations 
of the PIP2-binding gelsolin-peptide (160-QRLFQVKGRR-169) and 
subsequently added to 2.5 μΜ gelsolin and pp60c_src. Molar ratios 
of gelsolin/peptide: PIP2 are indicated on top. ci: control^ gelsolin 
(2.5 μΜ) phosphorylated with pp60c-src for 10 min without preincu-
bation of PIP2. c2: control2, gelsolin (2.5 μΜ) preincubated with a 
30-fold molar excess of PIP2 (75 μΜ) and subsequently phosphoryl-
ated with pp60c~src. The autoradiogram was exposed for 7 h at 
-80°C. 
I I Γ ^ Γ ^ Ί i i r 
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Fig. 3. Specificity of PIP2 in stimulating the phosphorylation of gel-
solin by pp60c_src. (Phospho)lipids (75 μΜ each) are shown on the 
X-axis and were preincubated with gelsolin (2.5 μΜ) for 30 min be-
fore pp60c_src was added. The stimulation of phosphorylation rela-
tive to the control (without PIP2) is represented on the 7-axis. The 
results are representative for three independent experiments. 
efficient phosphorylation of poly (Glu/Tyr) 4:1, a well-known 
substrate for tyrosine kinases [44] (data not shown). 
3.3. PIP2 does not activate pp6(F~s™ kinase activity but acts on 
the substrate 
Although PIP2 is known to interact with gelsolin and other 
actin-binding proteins [40,45,46], it cannot be excluded at this 
stage that the phospholipid acts as a stimulator for the kinase. 
For example, PIP2 has been shown to function as a cofactor 
for PLD [47] or as an enhancer for G-protein-coupled recep-
tor kinase activity [48]. To determine the mode of action of 
PIP2 in the phosphorylation of gelsolin, we phosphorylated 
gelsolin with pp60c~src after preincubation of PIP2 with a 
phosphoinositide-binding peptide derived from gelsolin. Var-
ious amounts of the PIP2-binding gelsolin peptide, 160-
QRLFQVKGRR-169 [49] were preincubated with PIP2 (75 
μΜ) and subsequently gelsolin was added. Upon addition of 
increasing concentrations of the PIP2-binding peptide, the 
phosphorylation of gelsolin was increasingly inhibited. At a 
1:1 molar ratio of peptide/PIP2, the stimulation of gelsolin 
phosphorylation was nearly completely abolished (Fig. 2). A 
1.5 molar excess of peptide over PIP2 reduced the phospho-
rylation by pp60c_src to control levels (Fig. 2). These results 
strongly suggest that PIP2 binds to gelsolin and converts it 
into a good substrate for pp60c~src. 
To eliminate the possibility that PIP2 could also activate 
pp60c_src under our experimental conditions, we used RCM-
lysozyme as an alternative substrate [44]. We observed no 
variations in the rate of tyrosine phosphorylation of the latter 
when PIP2 was added in the same concentrations as men-
tioned above (data not shown). Taken together, the lack of 
stimulation of pp60c~src activity by PIP2 and the efficient com-
petition between gelsolin and a PIP2-binding synthetic peptide 
derived from gelsolin indicate that the dramatically increased 
rate of phosphorylation is due solely to the PIP2-gelsolin 
interaction. 
3.4. Phospholipid-specificity in the stimulation of gelsolin 
phosphorylation 
To study the structural requirements that are necessary for 
a phospholipid to stimulate phosphorylation of gelsolin, we 
194 V. De Corte et allFEBS Letters 401 (1997) 191-196 
Fig. 4. Phosphorylation of fragmin, profilin and CapG by pp60c~src. 
A: Phosphorylation of fragmin. Fragmin (2.5 μΜ) was preincubated 
with PIP2 (75 μΜ) and phosphorylated with pp60
c~src for 10 min. 
c: control: phosphorylation of fragmin without PIP2. B: Phospho-
rylation of profilin. The phosphorylation of profilin (7 μΜ) was per-
formed as described in A in the presence of a 30-fold molar excess 
of PIP2. C: Phosphorylation of CapG. CapG (2.5 μΜ) was phos-
phorylated as described in A. The films were exposed for 8 h at 
room temperature. 
made a comparative study of the stimulatory effects of differ-
ent phospholipids. Of all phospholipids tested, PIP2 displayed 
the highest activity (Fig. 3). In line with previous observations 
regarding the inhibition of gelsolin's F-actin severing activity 
by several phospholipids [41], PIP was able to mimic the effect 
of PIP2 to a relatively high degree: indeed PIP caused a 16-
fold increase in phospho-gelsolin formation at a molar excess 
of 30, whereas PIP2 stimulated the activity by a factor of 25 
under identical concentrations. PI, on the other hand, did not 
significantly increase gelsolin phosphorylation. PA showed 
only a weak stimulatory effect whereas PI, PS, PC, PE and 
ceramide did not enhance the phosphorylation of gelsolin at 
all (Fig. 3). 
These findings underscore the specificity of PIP2 and in 
particular the phosphate groups of the inositol moiety that 
seem to be required for a full-scale effect. Upon binding of 
the phospholipid, gelsolin probably undergoes a conforma-
tional change exposing the pp60c_src target tyrosine residue(s). 
3.5. Other actin-binding and PIP2-binding proteins are similar 
substrates for pp60c~sm 
To examine the specificity of pp60c~src with regard to mem-
bers of this family, we also investigated the ability of pp60c~src 
to phosphorylate profilin, fragmin and CapG (three other 
actin- and PIP2-binding proteins) and studied the effect of 
PIP2 on phosphorylation. Under conditions similar to those 
described for gelsolin, we found that fragmin as well as pro-
filin and CapG were phosphorylated by pp60c" r c (Fig. 4). In 
addition PIP2, used at a 30-fold molar excess, significantly 
stimulated this activity. The stimulatory activity of PIP2 to-
wards these proteins was lower as compared to gelsolin. On 
average, we measured a 8- to 11-fold increase in phosphate 
incorporation (Fig. 4A,B,C). In the case of profilin and CapG 
the formation of two phosphotyrosine containing variants 
were observed. This was also verified by Western blot analysis 
with anti-phosphotyrosine antibodies (data not shown). 
3.6. Gelsolin phosphorylation by PKC is stimulated by PIP2 
Because profilin phosphorylation by PKC [22] was stimu-
lated by PIP2, we investigated whether gelsolin could also be 
phosphorylated by PKC. Indeed, we found that gelsolin was 
phosphorylated and the phosphorylation was stimulated 10-
fold in the presence of a 30-fold molar excess of PIP2 (Fig. 
5A). Also the autophosphorylation of PKC was stimulated by 
PIP2. The phospho-amino acid pattern revealed phosphoser-
ine as the major phospho-amino acid and to a lesser extent 
phosphothreonine (Fig. 5B). 
4. Discussion 
To our knowledge this is the first report demonstrating that 
gelsolin is a target for pp60c_src. PIP2 is necessary to obtain a 
significant degree of phosphorylation which amounts to 0.18 
mol phosphate/mol gelsolin after 90 min in the presence of 
equimolar amounts of PIP2 micelles. The strict dependence 
for PIP2 most likely explains why phosphorylation of gelsolin 
previously escaped detection. Our data provide the biochem-
ical background for earlier reports alluding to an association 
between pp60c~src and gelsolin in osteoclasts [25]. The mech-
anism of PIP2 stimulation is probably due to a conforma-
tional change in gelsolin induced by the phospholipid, result-
ing in the exposure of key tyrosine residues. The interaction of 
gelsolin with phospholipids has been reported to be specific 
for PIP2 and PIP [40,41]. Our comparative study with anionic 
and neutral phospholipids reflects the same specificity. 
Two-dimensional gel electrophoresis of phosphorylated gel-
solin revealed two major and at least two minor phospho-
variants, indicating that more than one tyrosine is involved 
(De Corte et al., unpublished results). PIP2 does not act on 
the tyrosine kinase since the phosphorylation rate of RCM-
lysozyme by pp60c_src was not affected by the phospholipid. 
The specificity of pp60c~src is nevertheless evidenced by the 
lack of tyrosine phosphorylation activity on gelsolin by 
pp56lck, rendering it as unlikely that gelsolin is a substrate 
for pp56lck in T lymphocytes, where both substrate and kinase 
are present [50,51]. This observation of substrate specificity 
runs parallel to the statement made by Cheng et al. [52] 
who argued that different tyrosine kinases assayed on different 
cdc2 peptide substrates displayed strict in vitro substrate spe-
cificities. 
The amounts of PIP2 that were used reflect actual physio-
Fig. 5. Phosphorylation of gelsolin by PKC. A: Gelsolin (2.5 μΜ) 
was preincubated with the indicated PIP2 concentration and phos-
phorylated with PKC for 10 min. c: control, gelsolin phosphoryl-
ated with PKC but without PIP2. The autoradiogram was exposed 
for 8 h at room temperature. B: Phospho-amino acid analysis of 
gelsolin phosphorylated with PKC in the presence of PIP2. pp60c_src 
phosphorylation of gelsolin in the presence of PIP2 is included for 
comparison. The phospho-amino acids were identified by their comi-
gration with standards that were detected by ninhydrin staining (PS, 
phosphoserine; PT, phosphothreonine; PY, phosphotyrosine). The 
autoradiogram was exposed for 3 h at room temperature. 
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logical concentrations [19] and considering the calculated Km 
value ( ~ 6 μΜ), it is reasonable to speculate that gelsolin may 
represent a true substrate for pp60c~src in various cell types. It 
is, however, likely that the phosphorylation occurs transiently 
and therefore may be difficult to detect in vivo. Significantly, 
half maximal stimulation of gelsolin phosphorylation only 
requires 15- to 20-fold molar excess of PIP2, whereas half 
maximal inhibition of actin severing activity of gelsolin re-
quires equimolar amounts of PIP2 micelles ( ~ 80-fold molar 
excess) [19]. 
Based on our observations we postulate that pp60c_src 
could be an additional regulator of the actin cytoskeleton 
through tyrosine phosphorylation of gelsolin. Many reports 
in the literature have emphasized a translocation event of 
pp60c~src to and from the cytoskeleton. For example, it has 
been demonstrated that pp60c~src translocates to the Triton 
X-100 insoluble cytoskeleton during platelet aggregation fol-
lowing thrombin stimulation [53,54]. Addition of platelet ac-
tivating factor (PAF), however, causes pp60c_src to translocate 
to the plasma membrane [55]. PIP2 is known to dissociate the 
actin-gelsolin complex [56] and mediates uncapping of gelso-
lin from the barbed ends of actin filaments after stimulation of 
platelets with the thrombin receptor-activating peptide [20] 
and allowing the filaments to grow at this end. PIP2 could 
convert gelsolin in a conformation favourable for phospho-
rylation by pp60c_src and therefore giving new properties to 
gelsolin which will be recognized by future studies involving 
the identification of the phosphorylated tyrosine residues and 
functional assays. 
Fragmin from P. polycephalum, mammalian profilin and 
CapG are also phosphorylated by pp60c_src and as for gelsolin 
this phosphorylation is stimulated by PIP2. PIP2 is known to 
regulate the actin-binding properties of these proteins 
[46,57,58]. These findings may point to a more general mech-
anism involving tyrosine phosphorylation of other actin-bind-
ing proteins, with PIP2 as the common denomenator [59]. 
Based on the structural and functional similarties between 
members of the gelsolin family, we hypothesize that severin 
from Dictyostelium discoideum and villin are also candidates 
for pp60c~src phosphorylation. A similar role for PIP2 may 
also apply to other cytoskeleton regulatory proteins involved 
in signal transduction pathways leading to microfilament re-
arrangements, such as vinculin [60] and cc-actinin [61]. 
As previously shown [22], profilin phosphorylation by PKC 
was stimulated in the presence of ΡΙΡ2· In addition we found 
that this mechanism also applies to gelsolin. Thus it appears 
that several actin-binding proteins, once they have bound 
PIP2, become good substrates for different protein kinases. 
Further analysis of these phosphorylations will help us to 
clarify their functional role and significance during agonist 
induced actin reorganization. 
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